Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 21,522 shares at $5.86 ($87K) on 2016-03-03, disclosed to the SEC on 2016-03-07.
Open-market purchase of $87k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.86 | 10,000 | $59K | 67.1% |
| 2 | $0.00 | 6,522 | $0 | 0.0% |
| 3 | $5.74 | 5,000 | $29K | 32.9% |
| Total | $4.06 avg | 21,522 | $87K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |